HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells
Open accessThe DOI matches its Crossref record; 215 of the 219 references it cites were found in a registry or an index; 87 of the 126 sources its claims cite were checked for support.
Abstract
In solid tumours, cancer cells exist within hypoxic microenvironments, and their metabolic adaptation to this hypoxia is driven by HIF-1 transcription factor, which is overexpressed in a broad range of human cancers. HIF inhibitors are under pre-clinical investigation and clinical trials, but there is evidence that hypoxic cancer cells can adapt metabolically to HIF-1 inhibition, which would provide a potential route for drug resistance. Here, we review accumulating evidence of such adaptions in carbohydrate and creatine metabolism and other HIF-1-independent mechanisms that might allow cancers to survive hypoxia despite anti-HIF-1 therapy...
Overview
CoChat Summary
TL;DR
This review argues that hypoxic cancer cells can maintain metabolism and survive even when HIF-1 is inhibited, using compensatory mechanisms in glucose, glutamine, lipid, and creatine metabolism plus epigenetic and signaling pathways. The authors conclude that targeting HIF-1 alone is unlikely to be enough and that combination strategies will probably be needed.
Key findings
- In HIF-1/2-deficient Hepa-1 c4 tumors, glycolysis still adapted to hypoxia: glucose uptake was unchanged by FDG-PET, ATP was about 20% of Hepa WT levels, and c4 tumors had a 4.5-fold higher AMP/ATP ratio with higher PFK-1 activity.
- In HIF-1α knockout HCT116 colorectal cancer cells, glucose uptake was maintained by GLUT14 regulated by HIF-2α, and creatine metabolism became important for survival; inhibition of creatine kinase B (CKB) reduced clonogenic potential and 3D spheroid growth under hypoxia.
- In Myc-overexpressing small cell lung cancer cells lacking HIF-1α, glutamine was critical and sufficient for ATP production: blocking glutaminase caused cell death, while glucose withdrawal did not affect viability.
- The review highlights multiple HIF-independent adaptation routes, including epigenetic reprogramming, post-translational SUMOylation, spatial clustering of glycolytic enzymes (“G bodies”), PI3K-Akt-mTOR, 2-hydroxyglutarate, and AMPK/PGC-1α signaling.
Methods
- Narrative review of prior studies on hypoxic cancer-cell metabolism, with emphasis on HIF-1-independent adaptation and resistance to anti-HIF therapy.
- Synthesizes evidence from multi-omics studies (transcriptomic, proteomic, metabolomic), genetic knockouts/knockdowns, pharmacologic inhibition, and hypoxic cell/tumor models.
- Main analysis is qualitative: comparison and integration of reported findings across cancer models, rather than a new experimental dataset or meta-analysis.
Limitations
- The paper does not report a systematic review protocol, formal search strategy, or quantitative synthesis; this is evident from the text.
- The authors explicitly note uncertainty in several areas, such as the exact mechanisms linking AMPK, 2-HG, PGC-1α, and hypoxia, and say that many findings “remain unknown” or “need further clarification.”
- The evidence base is heterogeneous and often model-specific; this is evident from the text, which repeatedly contrasts Hepa c4, HCT116, SCLC, and other systems, some with intact HIF-2 signaling and some without.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
57 Valid · 5 Not valid · 16 Not checked · 16 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“There was an accumulation of glycolytic intermediates, with a block of conversion of fructose-1,6-bisphosphate (Fru-1,6-BP) to dihydroxyacetone phosphate (DHAP) at the level of aldolase [58] rather than the earlier step of conversion of fructose-6-phosphate (Fru-6P) to Fru-1,6BP by PFK observed in c4 cells and tumors [16].”
§ HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells > 4. Glucose Metabolism in Cancer Cells in Deficient in HIF-1 under Hypoxia > 4.2. Auxiliary Functions of Glucose Uptake & Creatine Metabolism in Hypoxia
What the sources say
- Not checked — no full text of the sourcecites [58] Valli, 2019, Adaptation to HIF1a deletion in hypoxic cancer cells by upregulation of GLUT14 and creatine metabolism, Mol. Cancer Res. source
- Disputedcites [16] Golinska, M., Troy, H., Chung, Y.L., McSheehy, P.M., Mayr, M., Yin, X., Ly, L., Williams, K.J., Airley, R.E., and Harris, A.L. (2011). Adaptation to HIF-1 deficiency by upregulation of the AMP/ATP ratio and phosphofructokinase activation in hepatomas. BMC Cancer, 11. sourceExperimental — accuracy not yet measured
The citation to this paper attaches to the proposed PFK block in c4 cells and tumours, not to the aldolase finding attributed to Valli et al. The Discussion (page unavailable) says instead that PFK-1 activity was higher in c4 cells at their prevailing ATP/AMP ratio and that c4 tumours maintained a normal rate of glycolysis. (LLM, conf=0.89)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Several preclinical models of HIF-1-deficient tumours initially undergo a period of slow growth before subsequently demonstrating accelerated growth, suggesting the development of resistance and escape mechanisms from the inhibition of HIF-1 [13,14,15,16].”
§ HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells > 1. Introduction
What the sources say
- Partly supportedcites [13] Maxwell, 1997, Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth, Proc. Natl. Acad. Sci. USA sourceExperimental — accuracy not yet measured
The Results (Differences in Xenograft Growth; page unavailable) report that HIF-1-deficient c4 xenografts generally grew more slowly, with occasional faster-growing exceptions. The Discussion suggests possible escape mechanisms, but does not show that individual tumours first grew slowly and then accelerated, or establish this pattern across several preclinical models. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [14] Williams, 2002, A protective role for HIF-1 in response to redox manipulation and glucose deprivation: Implications for tumorigenesis, Oncogene source
- Not checked yetcites [15] Griffiths, 2002, Metabolic changes detected by in vivo magnetic resonance studies of HEPA-1 wild-type tumors and tumors deficient in hypoxia-inducible factor-1beta (HIF-1beta): Evidence of an anabolic role for the HIF-1 pathway, Cancer Res.
- Supportedcites [16] Golinska, M., Troy, H., Chung, Y.L., McSheehy, P.M., Mayr, M., Yin, X., Ly, L., Williams, K.J., Airley, R.E., and Harris, A.L. (2011). Adaptation to HIF-1 deficiency by upregulation of the AMP/ATP ratio and phosphofructokinase activation in hepatomas. BMC Cancer, 11. source
The Background states that in many cases HIF-1-deficient tumours accelerate after a period of slow growth and describes this as escape from impaired HIF-1 function. The Results and Discussion also report an initial growth delay followed by escape in the paper’s c4 tumour model. Page numbers are not available in the supplied copy. (LLM, conf=0.91)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Although in normal cells HIF-1 signalling occupies a central role in orchestrating the adaptive response of glycolysis to hypoxia, loss of HIF-1 in cancer cells and solid tumours paradoxically does not perturb the glycolytic phenotype [15,16,29].”
§ HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells > 2. Glucose Metabolism & Hypoxia To begin, we will briefly introduce the basic steps of glucose metabolism and examine how it changes under hypoxia. Glycolysis converts a single molecule of glucose into two molecules of pyruvate, with the net phosphorylation of 2 molecules of adenosine diphosphate (ADP) to adenosine triphosphate (ATP) and reduction of 2 molecules of nicotinamide adenosine dinucleotide (NAD) to NADH (reduced NAD) [1]. The fate of pyruvate is variable: it can be converted to lactate or carbon dioxide, depending on the availability of oxygen. In the presence of sufficient levels of oxygen, pyruvate is further oxidised by the tricarboxylic acid cycle (TCA) in the mitochondria, generating electron carriers to the electron transport chain which generate a further 36 molecules of ATP per molecule of glucose entering the glycolytic pathway [1]. In hypoxia, pyruvate remains within the cytoplasm and is converted to lactate in a reaction catalysed by lactate dehydrogenase [1]. This allows for the regeneration of NAD+ from NADH to maintain glycolysis during hypoxia [1]. High rates of glycolysis allow glycolytic intermediates to be channelled towards one-carbon metabolism to produce NADPH (reduced nicotinamide adenine dinucleotide phosphate) and nucleotides, enabling rapid biosynthesis for growth and proliferation [17]. This mechanism has been postulated to account for the Warburg effect, or aerobic glycolysis, by which proliferating cancer cells metabolise glucose via glycolysis even in the presence of oxygen [17,18]. The rate of glycolysis depends not only on the availability and uptake of glucose, but also on the kinetics of the metabolic enzymes that catalyse several rate-limiting steps along the pathway. Among these enzymes, hexokinase (HK), phosphofructokinase (PFK), and pyruvate kinase (PK) are allosterically regulated and have important roles in regulating glycolytic flux [19,20,21,22]. The initial switch that upregulates glycolysis in hypoxia has been traditionally attributed to the allosteric control of glycolytic enzymes by ATP [23]. This is followed by an important longer-term adaptive mechanism through HIF-1-dependent upregulation of the synthesis of glucose transporters and glycolytic enzymes [24,25,26,27]. This adaptive mechanism, which promotes survival of normal cells during hypoxia, is frequently hijacked by cancer cells, which then respire by aerobic glycolysis—the Warburg effect [18,28].
What the sources say
- Not checked yetcites [15] Griffiths, 2002, Metabolic changes detected by in vivo magnetic resonance studies of HEPA-1 wild-type tumors and tumors deficient in hypoxia-inducible factor-1beta (HIF-1beta): Evidence of an anabolic role for the HIF-1 pathway, Cancer Res.
- Partly supportedcites [16] Golinska, M., Troy, H., Chung, Y.L., McSheehy, P.M., Mayr, M., Yin, X., Ly, L., Williams, K.J., Airley, R.E., and Harris, A.L. (2011). Adaptation to HIF-1 deficiency by upregulation of the AMP/ATP ratio and phosphofructokinase activation in hepatomas. BMC Cancer, 11. sourceExperimental — accuracy not yet measured
The Conclusions (page unavailable) state that HIF-1-deficient c4 hepatoma tumours perform glycolysis at the normal rate despite reduced amounts of most glycolytic enzymes. This supports preserved glycolytic flux in that model, but not an unqualified claim about cancer cells and solid tumours generally; the enzyme changes also mean the glycolytic phenotype was not wholly unperturbed. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [29] Troy, 2005, Metabolic profiling of hypoxia-inducible factor-1β-deficient and wild type Hepa-1 cells: Effects of hypoxia measured by 1H magnetic resonance spectroscopy, Metabolomics source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“The cell membrane creatinine transporter SLC6A8 was found to be upregulated by hypoxia equally in both wild type and HIF-1α knockout HCT116 cells [54].”
§ HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells > 4. Glucose Metabolism in Cancer Cells in Deficient in HIF-1 under Hypoxia > 4.2. Auxiliary Functions of Glucose Uptake & Creatine Metabolism in Hypoxia
What the sources say
- Could not verifycites [54] Wise, 2011, Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability, Proc. Natl. Acad. Sci. USA sourceExperimental — accuracy not yet measured
The Results and Materials and Methods passages describe hypoxia experiments in SF188 and RCC4 cells, not HCT116 cells. Searches for SLC6A8 and for the claimed transporter comparison found no passage in our copy addressing its expression in wild-type versus HIF-1α-knockout HCT116 cells. No page numbers were provided. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Despite lacking functional HIF-1/2 pathways, Hepa c4 cells were able to upregulate glycolysis to the same extent as their wild type (Hepa WT) counterparts when cultured under hypoxia [15,16,29].”
§ HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells > 4. Glucose Metabolism in Cancer Cells in Deficient in HIF-1 under Hypoxia > 4.1. Allosteric Regulation of Glycolytic Enzymes under Hypoxia
What the sources say
- Not checked — no full text of the sourcecites [15] Griffiths, 2002, Metabolic changes detected by in vivo magnetic resonance studies of HEPA-1 wild-type tumors and tumors deficient in hypoxia-inducible factor-1beta (HIF-1beta): Evidence of an anabolic role for the HIF-1 pathway, Cancer Res.
- Supportedcites [16] Golinska, M., Troy, H., Chung, Y.L., McSheehy, P.M., Mayr, M., Yin, X., Ly, L., Williams, K.J., Airley, R.E., and Harris, A.L. (2011). Adaptation to HIF-1 deficiency by upregulation of the AMP/ATP ratio and phosphofructokinase activation in hepatomas. BMC Cancer, 11. source
The Background says c4 cells lacking a functioning HIF-1 pathway activated glycolysis under hypoxia to the same extent as WT cells. The Discussion adds that absent nuclear HIF-1β rules out HIF-2α pathways and reports comparable lactate output, an indicator of glycolytic flux, in hypoxic c4 and WT cultures. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [29] Troy, 2005, Metabolic profiling of hypoxia-inducible factor-1β-deficient and wild type Hepa-1 cells: Effects of hypoxia measured by 1H magnetic resonance spectroscopy, Metabolomics source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
40 more claims · 19 with their cited sources checked
Create a free account to see all 94 claims and to verify the 5 references still open.
- Probably not a substantial claim. 9
- It may state two separate claims as one. 44
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Zhang, 2008, Mitochondrial Autophagy Is an HIF-1-dependent Adaptive Metabolic Response to Hypoxia, J. Biol. Chem., 283, 10892, 10.1074/jbc.M800102200”
Cited work 10.1074/jbc.m800102200 · retracted 2023-08-07 · notice 10.1016/j.jbc.2023.105125 · this paper published 2021-09-09
Citations
Cites
1 retracted
Mitochondrial Autophagy Is an HIF-1-dependent Adaptive Metabolic Response to Hypoxia
Zhang, H., Bosch-Marce, M., Shimoda, L. A., Tan, Y. S., Baek, J. H., Wesley, J. B., Gonzalez, F. J., & Semenza, G. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800102200 · Cited by 1,601
RetractedUnderstanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
The Warburg Effect: How Does it Benefit Cancer Cells?
Liberti, M. V., & Locasale, J. W. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.12.001 · Cited by 5,150
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Mutational landscape and significance across 12 major cancer types
Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A., et al. (2013) · Nature · doi:10.1038/nature12634 · Cited by 4,419
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
Comprehensive molecular characterization of urothelial bladder carcinoma
Weinstein, J. N., Akbani, R., Broom, B. M., Wang, W., Verhaak, R. G. W., Liu, W., Ju, Z., Motter, T., Peng, B., Ryan, M., et al. (2014) · Nature · doi:10.1038/nature12965 · Cited by 3,107
Fundamentals of Cancer Metabolism
DeBerardinis, R. J., & Chandel, N. S. (2016) · Science Advances · doi:10.1126/sciadv.1600200 · Cited by 3,013
Comprehensive molecular characterization of urothelial bladder carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/za09-dk57 · Cited by 2,990
Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, M.-T., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.014 · Cited by 2,875
Figueroa, M. E., Abdel-Wahab, O., Lu, C., Ward, P. S., Patel, J., Shih, A., Li, Y., Bhagwat, N., Vasanthakumar, A., Fernandez, H. F., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.015 · Cited by 2,766
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy
Hardie, D. G. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2249 · Cited by 2,216
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.020 · Cited by 2,020
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., et al. (2013) · Nature · doi:10.1038/nature12040 · Cited by 1,990
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Lu, C., Ward, P. S., Kapoor, G. S., Rohle, D., Turcan, S., Abdel-Wahab, O., Edwards, C. R., Khanin, R., Figueroa, M. E., Melnick, A., et al. (2012) · Nature · doi:10.1038/nature10860 · Cited by 1,985
Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1.
Semenza, G. L., Roth, P. H., Fang, H. M., & Wang, G. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31580-6 · Cited by 1,897
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., et al. (2012) · Nature · doi:10.1038/nature10602 · Cited by 1,791
The emerging mechanisms of isoform-specific PI3K signalling
Vanhaesebroeck, B., Guillermet-Guibert, J., Graupera, M., & Bilanges, B. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2882 · Cited by 1,767
Semenza, G. L., Jiang, B.-H., Leung, S. W., Passantino, R., Concordet, J.-P., Maire, P., & Giallongo, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32529 · Cited by 1,752
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
Semenza, G. L. (2010) · Oncogene · doi:10.1038/onc.2009.441 · Cited by 1,712
Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Bellot, G., Garcia-Medina, R., Gounon, P., Chiche, J., Roux, D., Pouysségur, J., & Mazure, N. M. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00166-09 · Cited by 1,501
Hypoxia-inducible expression of tumor-associated carbonic anhydrases.
Wykoff, C. C., Beasley, N. J. P., Watson, P. H., Turner, K., Pastorek, J., Sibtain, A., Wilson, G. D., Turley, H., Talks, K., Maxwell, P. H., et al. (2000) · PubMed · Cited by 1,491
Akt Stimulates Aerobic Glycolysis in Cancer Cells
Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R., Zhuang, H., Cinalli, R. M., Alavi, A., Rudin, C. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2904 · Cited by 1,454
Direct regulation of TWIST by HIF-1α promotes metastasis
Yang, M.-H., Wu, M.-Z., Chiou, S.-H., Chen, P.-M., Chang, S.-Y., Liu, C.-J., Teng, S.-C., & Wu, K.-J. (2008) · Nature Cell Biology · doi:10.1038/ncb1691 · Cited by 1,345
Glutamine and cancer: cell biology, physiology, and clinical opportunities
Hensley, C. T., Wasti, A. T., & DeBerardinis, R. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69600 · Cited by 1,262
AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress
Jeon, S.-M., Chandel, N. S., & Hay, N. (2012) · Nature · doi:10.1038/nature11066 · Cited by 1,132
Epigenetics and gene expression
Gibney, E. R., & Nolan, C. M. (2010) · Heredity · doi:10.1038/hdy.2010.54 · Cited by 1,109
Maxwell, P. H., Dachs, G. U., Gleadle, J. M., Nicholls, L. G., Harris, A. L., Stratford, I. J., Hankinson, O., Pugh, C. W., & Ratcliffe, P. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8104 · Cited by 1,084
LKB1 modulates lung cancer differentiation and metastasis
Ji, H., Ramsey, M. R., Hayes, D. N., Fan, C., McNamara, K., Kozlowski, P., Torrice, C., Wu, M. C., Shimamura, T., Perera, S. A., et al. (2007) · Nature · doi:10.1038/nature06030 · Cited by 1,064
HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α
Arany, Z., Foo, S.-Y., Ma, Y., Ruas, J. L., Bommi-Reddy, A., Girnun, G., Cooper, M., Laznik, D., Chinsomboon, J., Rangwala, S. M., et al. (2008) · Nature · doi:10.1038/nature06613 · Cited by 1,054
Cockman, M. E., Masson, N., Mole, D. R., Jaakkola, P., Chang, G.-W., Clifford, S. C., Maher, E. R., Pugh, C. W., Ratcliffe, P. J., & Maxwell, P. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002740200 · Cited by 1,050
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
Chowdhury, R., Yeoh, K. K., Tian, Y., Hillringhaus, L., Bagg, E. A., Rose, N. R., Leung, I. K. H., Li, X. S., Woon, E. C. Y., Yang, M., et al. (2011) · The EMBO Reports · doi:10.1038/embor.2011.43 · Cited by 1,035
Amary, M. F., Bacsi, K., Maggiani, F., Damato, S., Halai, D., Berisha, F., Pollock, R., O'Donnell, P., Grigoriadis, A., Diss, T., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2913 · Cited by 1,023
Regulation of glycolysis by the hypoxia-inducible factor (HIF): Implications for cellular physiology
Kierans, S. J., & Taylor, C. T. (2021) · The Journal of Physiology · doi:10.1113/jp280572 · Cited by 1,015
Masson, N., Willam, C., Maxwell, P. H., Pugh, C. W., & Ratcliffe, P. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.18.5197 · Cited by 1,014
Minireview: The AMP-Activated Protein Kinase Cascade: The Key Sensor of Cellular Energy Status
Hardie, D. G. (2003) · Endocrinology · doi:10.1210/en.2003-0982 · Cited by 994
Semenza, G. L., Nejfelt, M. K., Chi, S. M., & Antonarakis, S. E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5680 · Cited by 990
Wise, D. R., Ward, P. S., Shay, J. E. S., Cross, J. R., Gruber, J. J., Sachdeva, U. M., Platt, J. M., DeMatteo, R. G., Simon, M. C., & Thompson, C. B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117773108 · Cited by 975
Tanimoto, K., Makino, Y., Pereira, T., & Poellinger, L. (2000) · The EMBO Journal · doi:10.1093/emboj/19.16.4298 · Cited by 928
AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo
Faubert, B., Boily, G., Izreig, S., Griss, T., Samborska, B., Dong, Z., Dupuy, F., Chambers, C., Fuerth, B. J., Viollet, B., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.001 · Cited by 911
Advances in Hypoxia-Inducible Factor Biology
Choudhry, H., & Harris, A. L. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.10.005 · Cited by 868
Is Glutamine a Conditionally Essential Amino Acid?
Lacey, J. M., & Wilmore, D. W. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1990.tb02967.x · Cited by 808
HIF-2α Promotes Hypoxic Cell Proliferation by Enhancing c-Myc Transcriptional Activity
Gordan, J. D., Bertout, J. A., Hu, C.-J., Diehl, J. A., & Simon, M. C. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.006 · Cited by 781
Environment impacts the metabolic dependencies of Ras-driven non-small cell lung cancer
Davidson, S. M., Papagiannakopoulos, T., Olenchock, B. A., Heyman, J. E., Keibler, M. A., Luengo, A., Bauer, M. R., Jha, A. K., O’Brien, J. P., Pierce, K. A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.01.007 · Cited by 737
Nutrient sensing and TOR signaling in yeast and mammals
González, A., & Hall, M. N. (2017) · The EMBO Journal · doi:10.15252/embj.201696010 · Cited by 732
Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation
Koivunen, P., Lee, S., Duncan, C. G., Lopez, G., Lu, G., Ramkissoon, S., Losman, J. A., Joensuu, P., Bergmann, U., Gross, S., et al. (2012) · Nature · doi:10.1038/nature10898 · Cited by 727
Self-citationDynamic Regulation of Histone Lysine Methylation by Demethylases
Shi, Y., & Whetstine, J. R. (2007) · Molecular Cell · doi:10.1016/j.molcel.2006.12.010 · Cited by 707
Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells
Yuneva, M., Zamboni, N., Oefner, P., Sachidanandam, R., & Lazebnik, Y. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200703099 · Cited by 690
HIF-1α induces cell cycle arrest by functionally counteracting Myc
Koshiji, M., Kageyama, Y., Pete, E. A., Horikawa, I., Barrett, J. C., & Huang, L. E. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600196 · Cited by 652
Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine
Zhang, J., Pavlova, N. N., & Thompson, C. B. (2017) · The EMBO Journal · doi:10.15252/embj.201696151 · Cited by 651
Tumour hypoxia causes DNA hypermethylation by reducing TET activity
Thienpont, B., Steinbacher, J., Zhao, H., D’Anna, F., Kuchnio, A., Ploumakis, A., Ghesquière, B., Van Dyck, L., Boeckx, B., Schoonjans, L., et al. (2016) · Nature · doi:10.1038/nature19081 · Cited by 635
Transcription Factor HIF-1 Is a Necessary Mediator of the Pasteur Effect in Mammalian Cells
Seagroves, T. N., Ryan, H. E., Lu, H., Wouters, B. G., Knapp, M., Thibault, P., Laderoute, K., & Johnson, R. S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3436-3444.2001 · Cited by 634
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
Massie, C. E., Lynch, A., Ramos‐Montoya, A., Boren, J., Stark, R., Fazli, L., Warren, A., Scott, H., Madhu, B., Sharma, N., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.158 · Cited by 624
Self-citationThe metabolite α-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR
Chin, R. M., Fu, X., Pai, M. Y., Vergnes, L., Hwang, H., Deng, G., Diep, S., Lomenick, B., Meli, V. S., Monsalve, G. C., et al. (2014) · Nature · doi:10.1038/nature13264 · Cited by 608
Wieman, H. L., Wofford, J. A., & Rathmell, J. C. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-07-0593 · Cited by 593
Reductive carboxylation supports redox homeostasis during anchorage-independent growth
Jiang, L., Shestov, A. A., Swain, P., Yang, C., Parker, S. J., Wang, Q. A., Terada, L. S., Adams, N. D., McCabe, M. T., Pietrak, B., et al. (2016) · Nature · doi:10.1038/nature17393 · Cited by 582
Ebert, B. L., Firth, J. D., & Ratcliffe, P. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29083 · Cited by 575
Rathmell, J. C., Fox, C. J., Plas, D. R., Hammerman, P. S., Cinalli, R. M., & Thompson, C. B. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.20.7315-7328.2003 · Cited by 572
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
Losman, J.-A., & Kaelin, W. G. (2013) · Genes & Development · doi:10.1101/gad.217406.113 · Cited by 570
Tardito, S., Oudin, A., Ahmed, S. U., Fack, F., Keunen, O., Zheng, L., Miletic, H., Sakariassen, P. Ø., Weinstock, A., Wagner, A., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3272 · Cited by 557
Jiang, B., Agani, F. H., Passaniti, A., & Semenza, G. L. (1997) · PubMed · Cited by 532
Marin-Valencia, I., Yang, C., Mashimo, T., Cho, S., Baek, H., Yang, X.-L., Rajagopalan, K. N., Maddie, M., Vemireddy, V., Zhao, Z., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.05.001 · Cited by 529
Hypoxia Induces Production of L-2-Hydroxyglutarate
Intlekofer, A. M., Dematteo, R. G., Venneti, S., Finley, L. W. S., Lu, C., Judkins, A. R., Rustenburg, A. S., Grinaway, P. B., Chodera, J. D., Cross, J. R., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.06.023 · Cited by 513
PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review)
Xie, Y., Shi, X., Sheng, K., Han, G., Li, W., Zhao, Q., Jiang, B., Feng, J., Li, J., & Gu, Y. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9713 · Cited by 505
Movafagh, S., Crook, S., & Vo, K. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25074 · Cited by 469
Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
Wong, C. C.-L., Gilkes, D. M., Zhang, H., Chen, J., Wei, H., Chaturvedi, P., Fraley, S. I., Wong, C.-M., Khoo, U.-S., Ng, I. O.-L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113483108 · Cited by 437
Extreme vulnerability of IDH1 mutant cancers to NAD+ depletion
Tateishi, K., Wakimoto, H., Iafrate, A. J., Tanaka, S., Loebel, F., Lelic, N., Wiederschain, D., Bedel, O., Deng, G., Zhang, B., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.11.006 · Cited by 433
Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate
Chakraborty, A. A., Laukka, T., Myllykoski, M., Ringel, A. E., Booker, M. A., Tolstorukov, M. Y., Meng, Y. J., Meier, S. R., Jennings, R. B., Creech, A. L., et al. (2019) · Science · doi:10.1126/science.aaw1026 · Cited by 432
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis
Terunuma, A., Putluri, N., Mishra, P., Mathé, E. A., Dorsey, T. H., Yi, M., Wallace, T. A., Issaq, H. J., Zhou, M., Killian, J. K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71180 · Cited by 428
Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation
Bardeesy, N., Sinha, M., Hezel, A. F., Signoretti, S., Hathaway, N. A., Sharpless, N. E., Loda, M., Carrasco, D. R., & DePinho, R. A. (2002) · Nature · doi:10.1038/nature01045 · Cited by 424
The role of dynamic enzyme assemblies and substrate channelling in metabolic regulation
Sweetlove, L. J., & Fernie, A. R. (2018) · Nature Communications · doi:10.1038/s41467-018-04543-8 · Cited by 416
Extracellular Metabolic Energetics Can Promote Cancer Progression
Loo, J. M., Scherl, A., Nguyen, A., Man, F. Y., Weinberg, E., Zeng, Z., Saltz, L., Paty, P. B., & Tavazoie, S. F. (2015) · Cell · doi:10.1016/j.cell.2014.12.018 · Cited by 393
Hypoxia induces rapid changes to histone methylation and reprograms chromatin
Batie, M., Frost, J., Frost, M., Wilson, J. W., Schofield, P., & Rocha, S. (2019) · Science · doi:10.1126/science.aau5870 · Cited by 385
HIFs, angiogenesis, and metabolism: Elusive enemies in breast cancer
de Heer, E. C., Jalving, M., & Harris, A. L. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137552 · Cited by 372
Oldham, W. M., Clish, C. B., Yang, Y., & Loscalzo, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.06.021 · Cited by 364
Zheng, B., Jeong, J. H., Asara, J. M., Yuan, Y.-Y., Granter, S. R., Chin, L., & Cantley, L. C. (2009) · Molecular Cell · doi:10.1016/j.molcel.2008.12.026 · Cited by 359
Huang, D., Li, T., Li, X., Zhang, L., Sun, L., He, X., Zhong, X., Jia, D., Song, L., Semenza, G. L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.028 · Cited by 352
Sun, R. C., & Denko, N. C. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.022 · Cited by 344
HIF-1 regulation: not so easy come, easy go
Koh, M. Y., Spivak-Kroizman, T. R., & Powis, G. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.08.002 · Cited by 339
Liao, D., Corle, C., Seagroves, T. N., & Johnson, R. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2701 · Cited by 339
Hypoxia signals autophagy in tumor cells via AMPK activity, independent of HIF-1, BNIP3, and BNIP3L
Papandreou, I., Lim, A. L., Laderoute, K., & Denko, N. C. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.84 · Cited by 334
Krieg, A. J., Rankin, E. B., Chan, D., Razorenova, O., Fernandez, S., & Giaccia, A. J. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00444-09 · Cited by 334
Emerling, B. M., Weinberg, F., Snyder, C., Burgess, Z., Mutlu, G. M., Viollet, B., Budinger, G. R. S., & Chandel, N. S. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.02.019 · Cited by 330
Comparative Metabolic Flux Profiling of Melanoma Cell Lines
Scott, D. A., Richardson, A. D., Filipp, F. V., Knutzen, C. A., Chiang, G. G., Ronai, Z. A., Osterman, A. L., & Smith, J. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.282046 · Cited by 328
Gameiro, P. A., Yang, J., Metelo, A. M., Pérez-Carro, R., Baker, R., Wang, Z., Arreola, A., Rathmell, W. K., Olumi, A., López-Larrubia, P., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.02.002 · Cited by 325
Andricovich, J., Perkail, S., Kai, Y., Casasanta, N., Peng, W., & Tzatsos, A. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.02.003 · Cited by 320
Control of Glycolysis through Regulation of PFK1: Old Friends and Recent Additions
Mor, I., Cheung, E. C., & Vousden, K. H. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010868 · Cited by 316
Hypoxia-inducible factors and the regulation of lipid metabolism
Mylonis, I., Simos, G., & Paraskeva, E. (2019) · Cells · doi:10.3390/cells8030214 · Cited by 316
HIF Inhibitors: Status of Current Clinical Development
Fallah, J., & Rini, B. I. (2019) · Current Oncology Reports · doi:10.1007/s11912-019-0752-z · Cited by 308
Choueiri, T. K., Bauer, T. M., Papadopoulos, K. P., Plimack, E. R., Merchan, J. R., McDermott, D. F., Michaelson, M. D., Appleman, L. J., Thamake, S., Perini, R. F., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01324-7 · Cited by 305
Evolution and regulatory role of the hexokinases
Cárdenas, M. L., Cornish-Bowden, A., & Ureta, T. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(97)00150-x · Cited by 302
Regulation of cell proliferation by hypoxia-inducible factors
Hubbi, M. E., & Semenza, G. L. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00279.2015 · Cited by 300
Oxygen sensing and hypoxia signalling pathways in animals: The implications of physiology for cancer
Ratcliffe, P. J. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.251470 · Cited by 294
miRNAs regulate the HIF switch during hypoxia: a novel therapeutic target
Serocki, M., Bartoszewska, S., Janaszak-Jasiecka, A., Ochocka, R. J., Collawn, J. F., & Bartoszewski, R. (2018) · Angiogenesis · doi:10.1007/s10456-018-9600-2 · Cited by 288
Pharmacologic Targeting of Hypoxia-Inducible Factors
Semenza, G. L. (2019) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021637 · Cited by 288
AMP ‐activated protein kinase: a key regulator of energy balance with many roles in human disease
Grahame Hardie, D. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12268 · Cited by 285
l -2-Hydroxyglutarate: An Epigenetic Modifier and Putative Oncometabolite in Renal Cancer
Shim, E.-H., Livi, C. B., Rakheja, D., Tan, J., Benson, D., Parekh, V., Kho, E.-Y., Ghosh, A. P., Kirkman, R., Velu, S., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0696 · Cited by 280
Grassian, A. R., Parker, S. J., Davidson, S. M., Divakaruni, A. S., Green, C. R., Zhang, X., Slocum, K. L., Pu, M., Lin, F., Vickers, C., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0772-t · Cited by 280
Kung, H.-N., Marks, J. R., & Chi, J.-T. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002229 · Cited by 277
Ros, S., & Schulze, A. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-8 · Cited by 269
Creatine metabolism: energy homeostasis, immunity and cancer biology
Kazak, L., & Cohen, P. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0365-5 · Cited by 265
ATP-citrate lyase: A mini-review
Chypre, M., Zaidi, N., & Smans, K. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.04.144 · Cited by 253
Hiraga, T., Kizaka-Kondoh, S., Hirota, K., Hiraoka, M., & Yoneda, T. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2355 · Cited by 242
Metabolism, Activity, and Targeting of D- and L-2-Hydroxyglutarates
Ye, D., Guan, K.-L., & Xiong, Y. (2018) · Trends in Cancer · doi:10.1016/j.trecan.2017.12.005 · Cited by 242
Alvarez-Tejado, M., Naranjo-Suárez, S., Jiménez, C., Carrera, A. C., Landázuri, M. O., & del Peso, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011688200 · Cited by 235
2-Hydroxyglutarate Inhibits ATP Synthase and mTOR Signaling
Fu, X., Chin, R. M., Vergnes, L., Hwang, H., Deng, G., Xing, Y., Pai, M. Y., Li, S., Ta, L., Fazlollahi, F., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.06.009 · Cited by 235
Lactate promotes glutamine uptake and metabolism in oxidative cancer cells
Pérez-Escuredo, J., Dadhich, R. K., Dhup, S., Cacace, A., Van Hée, V. F., De Saedeleer, C. J., Sboarina, M., Rodriguez, F., Fontenille, M.-J., Brisson, L., et al. (2016) · Cell Cycle · doi:10.1080/15384101.2015.1120930 · Cited by 231
Xiang, L., Mou, J., Shao, B., Wei, Y., Liang, H., Takano, N., Semenza, G. L., & Xie, G. (2019) · Cell Death & Disease · doi:10.1038/s41419-018-1291-5 · Cited by 223
AMPK Promotes p53 Acetylation via Phosphorylation and Inactivation of SIRT1 in Liver Cancer Cells
Lee, C.-W., Wong, L. L.-Y., Tse, E. Y.-T., Liu, H.-F., Leong, V. Y.-L., Lee, J. M.-F., Hardie, D. G., Ng, I. O.-L., & Ching, Y.-P. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0429 · Cited by 215
Lactate dehydrogenase A silencing in IDH mutant gliomas
Chesnelong, C., Chaumeil, M. M., Blough, M. D., Al-Najjar, M., Stechishin, O. D., Chan, J. A., Pieper, R. O., Ronen, S. M., Weiss, S., Luchman, H. A., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not243 · Cited by 210
A fundamental system of cellular energy homeostasis regulated by PGC-1α
Rohas, L. M., St-Pierre, J., Uldry, M., Jäger, S., Handschin, C., & Spiegelman, B. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702683104 · Cited by 208
Glycolytic Enzymes Coalesce in G Bodies under Hypoxic Stress
Jin, M., Fuller, G. G., Han, T., Yao, Y., Alessi, A. F., Freeberg, M. A., Roach, N. P., Moresco, J. J., Karnovsky, A., Baba, M., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.082 · Cited by 208
Salnikow, K., Kluz, T., Costa, M., Piquemal, D., Demidenko, Z. N., Xie, K., & Blagosklonny, M. V. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.6.1734-1741.2002 · Cited by 207
Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events
Liu, J., Lee, W., Jiang, Z., Chen, Z., Jhunjhunwala, S., Haverty, P. M., Gnad, F., Guan, Y., Gilbert, H. N., Stinson, J., et al. (2012) · Genome Research · doi:10.1101/gr.140988.112 · Cited by 200
A joint analysis of metabolomics and genetics of breast cancer
Tang, X., Lin, C.-C., Spasojevic, I., Iversen, E. S., Chi, J.-T., & Marks, J. R. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0415-9 · Cited by 198
Suppression of PGC-1α Is Critical for Reprogramming Oxidative Metabolism in Renal Cell Carcinoma
LaGory, E. L., Wu, C., Taniguchi, C. M., Ding, C.-K. C., Chi, J.-T., von Eyben, R., Scott, D. A., Richardson, A. D., & Giaccia, A. J. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.006 · Cited by 193
O'Hagan, K. A., Cocchiglia, S., Zhdanov, A. V., Tambuwala, M. M., Cummins, E. P., Monfared, M., Agbor, T. A., Garvey, J. F., Papkovsky, D. B., Taylor, C. T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808801106 · Cited by 193
Comerford, K. M., Leonard, M. O., Karhausen, J., Carey, R., Colgan, S. P., & Taylor, C. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337412100 · Cited by 185
Regulation of the citric acid cycle in mammalian systems
Williamson, J. R., & Cooper, R. H. (1980) · FEBS Letters · doi:10.1016/0014-5793(80)80572-2 · Cited by 180
The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway
Carbonneau, M., M. Gagné, L., Lalonde, M.-E., Germain, M.-A., Motorina, A., Guiot, M.-C., Secco, B., Vincent, E. E., Tumber, A., Hulea, L., et al. (2016) · Nature Communications · doi:10.1038/ncomms12700 · Cited by 180
Lee, S., & Griffiths, J. R. (2020) · Cancers · doi:10.3390/cancers12061616 · Cited by 179
Self-citationMutations in the d-2-Hydroxyglutarate Dehydrogenase Gene Cause d-2-Hydroxyglutaric Aciduria
Struys, E. A., Salomons, G. S., Achouri, Y., Van Schaftingen, E., Grosso, S., Craigen, W. J., Verhoeven, N. M., & Jakobs, C. (2005) · The American Journal of Human Genetics · doi:10.1086/427890 · Cited by 172
Lombardi, A. A., Gibb, A. A., Arif, E., Kolmetzky, D. W., Tomar, D., Luongo, T. S., Jadiya, P., Murray, E. K., Lorkiewicz, P. K., Hajnóczky, G., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12103-x · Cited by 160
Metabolic consequences of oncogenic IDH mutations
Parker, S. J., & Metallo, C. M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.05.003 · Cited by 158
Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma
Michealraj, K. A., Kumar, S. A., Kim, L. J. Y., Cavalli, F. M. G., Przelicki, D., Wojcik, J. B., Delaidelli, A., Bajic, A., Saulnier, O., MacLeod, G. D. A. H., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.047 · Cited by 156
Shao, R., Zhang, F.-P., Tian, F., Anders Friberg, P., Wang, X., Sjöland, H., & Billig, H. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.05.079 · Cited by 149
Wan, Z., Root‐Mccaig, J., Castellani, L., Kemp, B. E., Steinberg, G. R., & Wright, D. C. (2014) · Obesity · doi:10.1002/oby.20605 · Cited by 146
Acidic pH Is a Metabolic Switch for 2-Hydroxyglutarate Generation and Signaling
Nadtochiy, S. M., Schafer, X., Fu, D., Nehrke, K., Munger, J., & Brookes, P. S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.738799 · Cited by 143
Hypoxic Signaling During Tissue Repair and Regenerative Medicine
Nauta, T. D., van Hinsbergh, V. W. M., & Koolwijk, P. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151119791 · Cited by 139
Identification of a multienzyme complex for glucose metabolism in living cells
Kohnhorst, C. L., Kyoung, M., Jeon, M., Schmitt, D. L., Kennedy, E. L., Ramirez, J., Bracey, S. M., Luu, B. T., Russell, S. J., & An, S. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.783050 · Cited by 139
Sola‐Penna, M., Da Silva, D., Coelho, W. S., Marinho‐Carvalho, M. M., & Zancan, P. (2010) · IUBMB Life · doi:10.1002/iub.393 · Cited by 135
The strange case of AMPK and cancer: Dr Jekyll or Mr Hyde?
Vara-Ciruelos, D., Russell, F. M., & Hardie, D. G. (2019) · Open Biology · doi:10.1098/rsob.190099 · Cited by 135
Activation of AMPK under Hypoxia: Many Roads Leading to Rome
Dengler, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072428 · Cited by 133
Ao, A., Wang, H., Kamarajugadda, S., & Lu, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711677105 · Cited by 131
2-Hydroxyglutarate in Cancer Cells
Ježek, P. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2019.7902 · Cited by 130
LncRNA IDH1-AS1 links the functions of c-Myc and HIF1α via IDH1 to regulate the Warburg effect
Xiang, S., Gu, H., Jin, L., Thorne, R. F., Zhang, X. D., & Wu, M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711257115 · Cited by 129
The emerging role of KDM5A in human cancer
Yang, G., Zhu, M., Lu, X., Liu, Y., Lu, J., Leung, C., Ma, D., & Chen, J. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01041-1 · Cited by 129
Quantitative metabolome analysis profiles activation of glutaminolysis in glioma with IDH1 mutation
Ohka, F., Ito, M., Ranjit, M., Senga, T., Motomura, A., Motomura, K., Saito, K., Kato, K., Kato, Y., Wakabayashi, T., et al. (2014) · Tumor Biology · doi:10.1007/s13277-014-1784-5 · Cited by 128
Moon, J.-S., Jin, W.-J., Kwak, J.-H., Kim, H.-J., Yun, M.-J., KIM, J.-W., Park, S. W., & Kim, K.-S. (2011) · Biochemical Journal · doi:10.1042/bj20101104 · Cited by 125
Böttcher, M., Renner, K., Berger, R., Mentz, K., Thomas, S., Cardenas-Conejo, Z. E., Dettmer, K., Oefner, P. J., Mackensen, A., Kreutz, M., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1445454 · Cited by 124
The allosteric regulation of pyruvate kinase
Mattevi, A., Bolognesi, M., & Valentini, G. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00462-0 · Cited by 114
RNA promotes phase separation of glycolysis enzymes into yeast G bodies in hypoxia
Fuller, G. G., Han, T., Freeberg, M. A., Moresco, J. J., Ghanbari Niaki, A., Roach, N. P., Yates, J. R., Myong, S., & Kim, J. K. (2020) · eLife · doi:10.7554/elife.48480 · Cited by 113
Wan, W., Peng, K., Li, M., Qin, L., Tong, Z., Yan, J., Shen, B., & Yu, C. (2017) · Oncogene · doi:10.1038/onc.2017.13 · Cited by 110
Colvin, H., Nishida, N., Konno, M., Haraguchi, N., Takahashi, H., Nishimura, J., Hata, T., Kawamoto, K., Asai, A., Tsunekuni, K., et al. (2016) · Scientific Reports · doi:10.1038/srep36289 · Cited by 109
Salamanca-Cardona, L., Shah, H., Poot, A. J., Correa, F. M., Di Gialleonardo, V., Lui, H., Miloushev, V. Z., Granlund, K. L., Tee, S. S., Cross, J. R., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.10.001 · Cited by 106
ERRα as a Bridge Between Transcription and Function: Role in Liver Metabolism and Disease
Xia, H., Dufour, C. R., & Giguère, V. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00206 · Cited by 103
(2002) · PubMed · Cited by 101
Self-citationChromatin and oxygen sensing in the context of JmjC histone demethylases
Shmakova, A., Batie, M., Druker, J., & Rocha, S. (2014) · Biochemical Journal · doi:10.1042/bj20140754 · Cited by 99
ADHFE1 is a breast cancer oncogene and induces metabolic reprogramming
Mishra, P., Tang, W., Putluri, V., Dorsey, T. H., Jin, F., Wang, F., Zhu, D., Amable, L., Deng, T., Zhang, S., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93815 · Cited by 99
The altered metabolism of tumors: HIF-1 and its role in the Warburg effect
Stubbs, M., & Griffiths, J. R. (2009) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2009.10.027 · Cited by 97
Self-citationAkt and Hypoxia-Inducible Factor-1 Independently Enhance Tumor Growth and Angiogenesis
Arsham, A. M., Plas, D. R., Thompson, C. B., & Simon, M. C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2239 · Cited by 96
Regulation of Hypoxia-Inducible Genes by PGC-1α
Shoag, J., & Arany, Z. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.181636 · Cited by 96
Das, B., Pal, B., Bhuyan, R., Li, H., Sarma, A., Gayan, S., Talukdar, J., Sandhya, S., Bhuyan, S., Gogoi, G., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2847 · Cited by 92
Wu, Q., Tian, Y., Zhang, J., Tong, X., Huang, H., Li, S., Zhao, H., Tang, Y., Yuan, C., Wang, K., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716589115 · Cited by 91
Molecular Crosstalk Between MYC and HIF in Cancer
Li, Y., Sun, X.-X., Qian, D. Z., & Dai, M.-S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.590576 · Cited by 89
Mitochondrial energy metabolism is markedly impaired by d-2-hydroxyglutaric acid in rat tissues
Latini, A., da Silva, C. G., Ferreira, G. C., Schuck, P. F., Scussiato, K., Sarkis, J. J., Dutra Filho, C. S., Wyse, A. T. S., Wannmacher, C. M. D., & Wajner, M. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2005.05.002 · Cited by 88
Reitman, Z. J., Duncan, C. G., Poteet, E., Winters, A., Yan, L.-J., Gooden, D. M., Spasojevic, I., Boros, L. G., Yang, S.-H., & Yan, H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.575183 · Cited by 86
Chen, J.-Y., Lai, Y.-S., Tsai, H., Kuo, C.-C., Yen, B. L., Yeh, S., Sun, H. S., & Hung, W.-C. (2016) · Scientific Reports · doi:10.1038/srep32428 · Cited by 83
Head, S. A., Shi, W. Q., Yang, E. J., Nacev, B. A., Hong, S. Y., Pasunooti, K. K., Li, R.-J., Shim, J. S., & Liu, J. O. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.6b00849 · Cited by 82
Váraljai, R., Islam, A. B. M. M. K., Beshiri, M. L., Rehman, J., Lopez-Bigas, N., & Benevolenskaya, E. V. (2015) · Genes & Development · doi:10.1101/gad.264036.115 · Cited by 81
Hypoxia Increases Androgen Receptor Activity in Prostate Cancer Cells
Park, S.-Y., Kim, Y.-J., Gao, A. C., Mohler, J. L., Onate, S. A., Hidalgo, A. A., Ip, C., Park, E.-M., Yoon, S. Y., & Park, Y.-M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1341 · Cited by 81
Williams, K. J., Telfer, B. A., Airley, R. E., Peters, H. P., Sheridan, M. R., van der Kogel, A. J., Harris, A. L., & Stratford, I. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205047 · Cited by 81
Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathways
Valli, A., Rodriguez, M., Moutsianas, L., Fischer, R., Fedele, V., Huang, H.-L., Van Stiphout, R., Jones, D., Mccarthy, M., Vinaxia, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3058 · Cited by 79
Small Ubiquitin-related Modifier (SUMO)-1 Promotes Glycolysis in Hypoxia
Agbor, T. A., Cheong, A., Comerford, K. M., Scholz, C. C., Bruning, U., Clarke, A., Cummins, E. P., Cagney, G., & Taylor, C. T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.115931 · Cited by 68
The roles of chromatin-remodelers and epigenetic modifiers in kidney cancer
Liao, L., Testa, J. R., & Yang, H. (2015) · Cancer Genetics · doi:10.1016/j.cancergen.2015.02.008 · Cited by 64
Rousset, C. I., Leiper, F. C., Kichev, A., Gressèns, P., Carling, D., Hagberg, H., & Thornton, C. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13034 · Cited by 64
The effects of 2-hydroxyglutarate on the tumorigenesis of gliomas
Reiter–Brennan, C., Semmler, L., & Klein, A. (2018) · Współczesna Onkologia · doi:10.5114/wo.2018.82642 · Cited by 63
Phosphofructokinase relocalizes into subcellular compartments with liquid-like properties in vivo
Jang, S., Zhao, X., Lagoy, R. C., Jawerth, L. M., Gonzalez, I. J., Singh, M. K., Prashad, S., Kim, H. S., Patel, A., Albrecht, D. R., et al. (2020) · Biophysical Journal · doi:10.1016/j.bpj.2020.08.002 · Cited by 63
Regulation of lipid droplet homeostasis by hypoxia inducible lipid droplet associated HILPDA
Rodriguez, M. A. D. L. R., & Kersten, S. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158738 · Cited by 62
Gonsalves, W. I., Ramakrishnan, V., Hitosugi, T., Ghosh, T., Jevremovic, D., Dutta, T., Sakrikar, D., Petterson, X.-M., Wellik, L., Kumar, S. K., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.94543 · Cited by 57
The Role of Sumoylation in the Response to Hypoxia: An Overview
Filippopoulou, C., Simos, G., & Chachami, G. (2020) · Cells · doi:10.3390/cells9112359 · Cited by 56
Cui, J., Quan, M., Xie, D., Gao, Y., Guha, S., Fallon, M. B., Chen, J., & Xie, K. (2020) · Oncogene · doi:10.1038/s41388-019-1051-8 · Cited by 55
Seo, K., Seo, S., Ki, S. H., & Shin, S. M. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.11.014 · Cited by 54
Leek, R. D., Stratford, I., & Harris, A. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2184 · Cited by 53
Yim, S. H., Shah, Y., Tomita, S., Morris, D. H., Gavrilova, O., Lambert, G., Ward, J. M., & Gonzalez, F. J. (2006) · Hepatology · doi:10.1002/hep.21284 · Cited by 49
Jonasch, E., Donskov, F., Iliopoulos, O., Rathmell, W. K., Narayan, V., Maughan, B. L., Oudard, S., Else, T., Maranchie, J. K., Welsh, S. J., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.2020.38.15_suppl.5003 · Cited by 42
Reductive carboxylation and 2-hydroxyglutarate formation by wild-type IDH2 in breast carcinoma cells
Smolková, K., Dvořák, A., Zelenka, J., Vítek, L., & Ježek, P. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.05.012 · Cited by 40
Baresic, M., Salatino, S., Kupr, B., van Nimwegen, E., & Handschin, C. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01710-13 · Cited by 40
Hu, M.-Y., Chen, X., Ma, L., Ma, Y., Li, Y., Song, H.-H., Xu, J.-J., Zhou, L., Li, X., Jiang, Y.-H., et al. (2019) · Journal of Cancer · doi:10.7150/jca.28299 · Cited by 40
Brunner, A. M., Neuberg, D. S., Wander, S. A., Sadrzadeh, H., Ballen, K. K., Amrein, P. C., Attar, E. C., Hobbs, G. S., Chen, Y., Perry, A. M., et al. (2018) · Cancer · doi:10.1002/cncr.31729 · Cited by 36
Bardella, C., Olivero, M., Lorenzato, A., Geuna, M., Adam, J., O'Flaherty, L., Rustin, P., Tomlinson, I., Pollard, P. J., & Di Renzo, M. F. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06160-11 · Cited by 33
Li, W., Chen, C., Zhao, X., Ye, H., Zhao, Y., Fu, Z., Pan, W., Zheng, S., Wei, L., Nong, T., et al. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13202 · Cited by 32
Myc-induced glutaminolysis bypasses HIF-driven glycolysis in hypoxic small cell lung carcinoma cells
Thorén, M. M., Vaapil, M., Staaf, J., Planck, M., Johansson, M. E., Mohlin, S., & Påhlman, S. (2017) · Oncotarget · doi:10.18632/oncotarget.16904 · Cited by 31
Golinska, M., Troy, H., Chung, Y.-L., McSheehy, P. M., Mayr, M., Yin, X., Ly, L., Williams, K. J., Airley, R. E., Harris, A. L., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-198 · Cited by 29
Self-citationDeprivation of glutamine in cell culture reveals its potential for treating cancer
Rubin, H. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815968116 · Cited by 29
A novel colistin adjuvant identified by virtual screening for ArnT inhibitors
Ghirga, F., Stefanelli, R., Cavinato, L., Lo Sciuto, A., Corradi, S., Quaglio, D., Calcaterra, A., Casciaro, B., Loffredo, M. R., Cappiello, F., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa200 · Cited by 28
Valli, A., Morotti, M., Zois, C. E., Albers, P. K., Soga, T., Feldinger, K., Fischer, R., Frejno, M., McIntyre, A., Bridges, E., et al. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0315 · Cited by 27 · cited 1×
“Another interesting issue is that the upregulation of glucose transport by induction of GLUT14 that was observed by Valli et al. (2019) involved the activation of HIF-2 [58].”
Background
Cited by
Tumor glycolysis, an essential sweet tooth of tumor cells
Paul, S., Ghosh, S., & Kumar, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.09.007 · Cited by 449
Targeting the tumor microenvironment: Potential strategy for cancer therapeutics
Babar, Q., Saeed, A., Tabish, T. A., Sarwar, M., & Thorat, N. D. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166746 · Cited by 124
Hypoxia-inducible factor in breast cancer: role and target for breast cancer treatment
Zhi, S., Chen, C., Huang, H., Zhang, Z., Zeng, F., & Zhang, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1370800 · Cited by 105
Chang, Y., Chan, M., Yang, Y., Li, C., & Hsiao, M. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216179 · Cited by 83
The Role of Hypoxia-Inducible Factor-1 Alpha in Renal Disease
Liu, H., Li, Y., & Xiong, J. (2022) · Molecules · doi:10.3390/molecules27217318 · Cited by 83
Metadata
- Authors
- Lee, S.-H., Golinska, M., & Griffiths, J. R.
- Affiliations
- Hospital Sultanah Bahiyah (MY)
- University of Cambridge (GB)
- Corresponding author
- Lee, Shen-Han
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2021-09-09
- Volume
- 10
- Issue
- 9
- Pages
- 2371
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC8472468
- OpenAlex
- W3197266090
- Cited by
- 169
- References
- 219
- Citations by year
- 2026: 31 · 2025: 48 · 2024: 50 · 2023: 22 · 2022: 18
- FWCI
- 2.71
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo
- Apollo (cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- HIF-1, hypoxia, cancer metabolism, metabolic adaptation, HIF-1 inhibitors, drug resistance, ARNT, HIF-2, creatine metabolism, glucose metabolism, glutamine metabolism, lipid metabolism, epigenetic regulation, post-translational modification, c-Myc, PI3K/Akt, 2-hydroxyglutarate, AMPK, tumor hypoxia
- MeSH terms
- Adaptation, Physiological, Animals, Humans, Neoplasms, Signal Transduction, Cell Hypoxia, Hypoxia-Inducible Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.